Patents Assigned to Surface Oncology, LLC
  • METHODS OF TREATING A TUMOR
    Publication number: 20260167716
    Abstract: The present disclosure relates to methods of treating a tumor in a subject in need thereof comprising administering an IL-27 inhibiting agent, wherein the subject is identified as having a tumor that (i) expresses WSX-1, (ii) comprises one or more immune cell that expresses IL-27, (iii) or both (i) and (ii).
    Type: Application
    Filed: October 30, 2023
    Publication date: June 18, 2026
    Applicant: SURFACE ONCOLOGY, LLC
    Inventors: Ricard MASIA, Jonathan HILL, Secil KOSEOGLU, Benjamin H. LEE, Yu YANG
  • Anti-IL-27 antibodies and uses thereof
    Patent number: 12630624
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Grant
    Filed: April 6, 2022
    Date of Patent: May 19, 2026
    Assignee: SURFACE ONCOLOGY, LLC
    Inventors: Jonathan Hill, Scott Chappel, Michael Gladstone, Bianka Prinz, Andrew Lake, Christine Miller, Kerry White, Jing Hua, Pamela M. Holland, Matthew Rausch, Devapregasan Moodley
  • Anti-IL-27 antibodies and uses thereof
    Patent number: 12577299
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof at a dose of at least about 0.003 mg/kg to at least about 20 mg/kg.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: March 17, 2026
    Assignee: SURFACE ONCOLOGY, LLC
    Inventors: Alison O'Neill, Lauren Harshman, Jonathan Hill, Jou-Ku Chung, Kerry White, Robert Ross, Benjamin Lee
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20260055176
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: June 12, 2025
    Publication date: February 26, 2026
    Applicant: Surface Oncology, LLC
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY, Gege TAN
  • Anti-IL-27 antibodies and uses thereof
    Patent number: 12358978
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: July 15, 2025
    Assignee: SURFACE ONCOLOGY, LLC
    Inventors: Jonathan Hill, Scott Chappel, Michael Gladstone, Bianka Prinz, Andrew Lake, Christine Miller, Kerry White, Jing Hua, Pamela M. Holland, Matthew Rausch, Devapregasan Moodley, Gege Tan
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20250154244
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 15, 2025
    Applicant: SURFACE ONCOLOGY, LLC
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY
  • Anti-CD112R Compositions and Methods
    Publication number: 20250051449
    Abstract: The invention provides anti-CD112R antibody compositions and their use in treating cancer.
    Type: Application
    Filed: October 29, 2024
    Publication date: February 13, 2025
    Applicant: Surface Oncology, LLC
    Inventors: Bianka PRINZ, Nadthakarn BOLAND, Kevin SCHUTZ, John BUKOWSKI, Jennifer SYMONDS, James MOHAN, Marisella Panduro SICHEVA
  • Anti-CD112R compositions and methods
    Patent number: 12162941
    Abstract: The invention provides anti-CD112R antibody compositions and their use in treating cancer.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: December 10, 2024
    Assignee: Surface Oncology, LLC
    Inventors: Bianka Prinz, Nadthakarn Boland, Kevin Schutz, John Bukowski, Jennifer Symonds, James Mohan, Marisella Panduro Sicheva
  • Anti-IL-27 Antibodies and Uses Thereof
    Publication number: 20240199732
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: April 27, 2023
    Publication date: June 20, 2024
    Applicant: Surface Oncology, LLC
    Inventors: Jamie Strand, Jonathan Hill, Devan Moodley